The progression rate of aortic stenosis: key to tailoring the management and potential target for treatment
暂无分享,去创建一个
M. Cameli | C. Santoro | A. D’Andrea | R. Esposito | G. Mandoli | G. Benfari | A. Malagoli | F. Bandera | V. Evola | M. Setti | E. Tafciu | Martina Setti
[1] Y. Bossé,et al. Genetic and In Vitro Inhibition of PCSK9 and Calcific Aortic Valve Stenosis , 2020, JACC. Basic to translational science.
[2] S. Nistri,et al. The right parasternal window: when Doppler-beam alignment may be life-saving in patients with aortic valve stenosis. , 2020, Journal of cardiovascular medicine.
[3] M. Markl,et al. The Role of Imaging of Flow Patterns by 4D Flow MRI in Aortic Stenosis. , 2019, JACC. Cardiovascular imaging.
[4] M. Dweck,et al. Imaging and Impact of Myocardial Fibrosis in Aortic Stenosis , 2019, JACC. Cardiovascular imaging.
[5] M. Desai,et al. Distribution and Prognostic Significance of Left Ventricular Global Longitudinal Strain in Asymptomatic Significant Aortic Stenosis: An Individual Participant Data Meta-Analysis. , 2019, JACC. Cardiovascular imaging.
[6] Jeroen J. Bax,et al. Outcomes of Patients With Asymptomatic Aortic Stenosis Followed Up in Heart Valve Clinics , 2018, JAMA cardiology.
[7] C. Vassanelli,et al. Concomitant mitral regurgitation and aortic stenosis: one step further to low-flow preserved ejection fraction aortic stenosis , 2018, European heart journal cardiovascular Imaging.
[8] J. Forman,et al. Effect Modifications of Lipid-Lowering Therapy on Progression of Aortic Stenosis (from the Simvastatin and Ezetimibe in Aortic Stenosis [SEAS] Study). , 2017, The American journal of cardiology.
[9] Helmut Baumgartner,et al. [2017 ESC/EACTS Guidelines for the management of valvular heart disease]. , 2017, Kardiologia polska.
[10] M. Yacoub,et al. Effect of Side-Specific Valvular Shear Stress on the Content of Extracellular Matrix in Aortic Valves , 2016, Cardiovascular Engineering and Technology.
[11] A. Gori,et al. Feasibility and relevance of right parasternal view for assessing severity and rate of progression of aortic valve stenosis in primary care. , 2017, International journal of cardiology.
[12] Y. Bossé,et al. Systolic hypertension and progression of aortic valve calcification in patients with aortic stenosis: results from the PROGRESSA study , 2017, European heart journal cardiovascular Imaging.
[13] M. Leon,et al. Medical Treatment of Aortic Stenosis , 2016, Circulation.
[14] C. Izumi,et al. Predictors of Rapid Progression and Clinical Outcome of Asymptomatic Severe Aortic Stenosis. , 2016, Circulation journal : official journal of the Japanese Circulation Society.
[15] A. Vahanian,et al. Sex Differences in the Progression of Aortic Stenosis and Prognostic Implication: The COFRASA-GENERAC Study. , 2016, JACC. Cardiovascular imaging.
[16] Y. Bossé,et al. Oxidized Phospholipids, Lipoprotein(a), and Progression of Calci fi c Aortic Valve Stenosis , 2017 .
[17] M. Dweck,et al. Calcification in Aortic Stenosis: The Skeleton Key. , 2015, Journal of the American College of Cardiology.
[18] Catherine M. Otto,et al. Aortic-valve stenosis--from patients at risk to severe valve obstruction. , 2014, The New England journal of medicine.
[19] E. V. van Beek,et al. 18F-Sodium Fluoride Uptake Is a Marker of Active Calcification and Disease Progression in Patients With Aortic Stenosis , 2014, Circulation. Cardiovascular imaging.
[20] Jonathan T. Butcher,et al. The living aortic valve: From molecules to function , 2014, Global cardiology science & practice.
[21] Kathleen F. Kerr,et al. Genetic associations with valvular calcification and aortic stenosis. , 2013, The New England journal of medicine.
[22] M. Dweck,et al. Calcific aortic stenosis: a disease of the valve and the myocardium. , 2012, Journal of the American College of Cardiology.
[23] Jennifer Taylor,et al. ESC/EACTS Guidelines on the management of valvular heart disease. , 2012, European heart journal.
[24] R. Bonow,et al. Hemodynamic progression and outcome of asymptomatic aortic stenosis in primary care. , 2012, The American journal of cardiology.
[25] E. Aikawa,et al. Molecular Imaging Insights Into Early Inflammatory Stages of Arterial and Aortic Valve Calcification , 2011, Circulation research.
[26] R. Kronmal,et al. Bisphosphonate Use and Prevalence of Valvular and Vascular Calcification in Women MESA (The Multi-Ethnic Study of Atherosclerosis). , 2010, Journal of the American College of Cardiology.
[27] K. Teo,et al. Effect of Lipid Lowering With Rosuvastatin on Progression of Aortic Stenosis: Results of the Aortic Stenosis Progression Observation: Measuring Effects of Rosuvastatin (ASTRONOMER) Trial , 2010, Circulation.
[28] J. Chambers,et al. Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis. , 2008, The New England journal of medicine.
[29] D. Srivastava,et al. Mutations in NOTCH1 cause aortic valve disease , 2005, Nature.
[30] R. Prescott,et al. A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis. , 2005, The New England journal of medicine.
[31] R. Bergemann,et al. Can progression of valvar aortic stenosis be predicted accurately? , 2003, The Annals of thoracic surgery.
[32] Philippe Ravaud,et al. A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease. , 2003, European heart journal.
[33] B. Janerot-Sjöberg,et al. T lymphocyte infiltration in non-rheumatic aortic stenosis: a comparative descriptive study between tricuspid and bicuspid aortic valves , 2002, Heart.
[34] C. Otto. Calcification of bicuspid aortic valves , 2002, Heart.
[35] M. Schemper,et al. Predictors of outcome in severe, asymptomatic aortic stenosis. , 2000, The New England journal of medicine.
[36] R. Pai,et al. New insights into the progression of aortic stenosis: implications for secondary prevention. , 2000, Circulation.
[37] C M Otto,et al. Prospective study of asymptomatic valvular aortic stenosis. Clinical, echocardiographic, and exercise predictors of outcome. , 1997, Circulation.
[38] J. Thomas,et al. Progression of Aortic Stenosis in 394 Patients: Relation to Changes in Myocardial and Mitral Valve Dysfunction , 1995, Journal of the American College of Cardiology.
[39] S. Davies,et al. Progression of aortic stenosis. Role of age and concomitant coronary artery disease. , 1994, Chest.
[40] W. Roberts,et al. Early descriptions of aortic valve stenosis. , 1993, American heart journal.
[41] C. Rusconi,et al. Rate of progression of valvular aortic stenosis in adults. , 1992, The American journal of cardiology.
[42] W. P. Harvey,et al. Development and progression of aortic valve stenosis: Atherosclerosis risk factors—a causal relationship? a clinical morphologic study , 1991, Clinical cardiology.
[43] S. Davies,et al. Progression of valvar aortic stenosis: a long-term retrospective study. , 1991, European heart journal.
[44] J. Seward,et al. Progression of aortic stenosis in adults: new appraisal using Doppler echocardiography. , 1990, American heart journal.
[45] C. Otto,et al. Hemodynamic progression of aortic stenosis in adults assessed by Doppler echocardiography. , 1989, Journal of the American College of Cardiology.
[46] A. Selzer,et al. Patterns of Progression of Aortic Stenosis: A Longitudinal Hemodynamic Study , 1982, Circulation.
[47] B. Brundage,et al. Rate of progression of severity of valvular aortic stenosis in the adult. , 1979, American heart journal.
[48] M. Dunn,et al. Progression of aortic stenosis. , 1979, Chest.
[49] B. Carabello,et al. Aortic stenosis , 2018, Rapid Cardiac Care.